Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: A case-matched comparison

Ryu, 2007, Contemporary clinical trials in uterine corpus malignancies, J Gynecol Oncol, 50, 1299

Brooks, 2004, Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989–1999, Gynecol Oncol, 93, 204, 10.1016/j.ygyno.2003.12.029

D’Angelo, 2010, Uterine sarcomas: a review, Gynecol Oncol, 116, 131, 10.1016/j.ygyno.2009.09.023

2003, World Health Organization classification of tumours

Wang, 2002, Cervical and peritoneal fluid cytology of uterine sarcomas, Acta Cytol, 46, 465, 10.1159/000326862

Tanaka, 2004, Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings, J Magn Reson Imaging, 20, 998, 10.1002/jmri.20207

Sagae, 2004, Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan, Oncology, 67, 33, 10.1159/000080283

Duk, 1994, CA-125 in serum and tumor from patients with uterine sarcoma, Int J Gynecol Cancer, 4, 156, 10.1046/j.1525-1438.1994.04030156.x

Huang, 2007, Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma, Gynecol Oncol, 107, 513, 10.1016/j.ygyno.2007.08.060

Hoskins, 2008, Preoperative tumor markers at diagnosis in women with malignant mixed mullerian tumors/carcinosarcoma of the uterus, Int J Gynecol Cancer, 18, 1200, 10.1111/j.1525-1438.2007.01187.x

Shan, 2009, The inflammatory network: bridging senescent stroma and epithelial tumorigenesis, Front Biosci, 14, 4044, 10.2741/3511

Den Ouden, 1997, Whole blood cell counts and leucocyte differentials in patients with benign or malignant ovarian tumours, Eur J Obstet Gynecol Reprod Biol, 72, 73, 10.1016/S0301-2115(96)02662-0

Jilma, 1999, Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin, Am J Respir Crit Care Med, 159, 857, 10.1164/ajrccm.159.3.9805087

Cho, 2009, Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment, Cancer Immunol Immunother, 58, 15, 10.1007/s00262-008-0516-3

Walsh, 2005, Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer, J Surg Oncol, 91, 181, 10.1002/jso.20329

Herishanu, 2006, Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia, Eur J Haematol, 76, 516, 10.1111/j.1600-0609.2006.00658.x

Olivares, 2006, Normal values of the hemogram and other hematological variables in subjects over 60 years old, Rev Med Chil, 122, 1289

Ruka, 2001, Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance, Ann Oncol, 12, 1423, 10.1023/A:1012527006566

World Health Organization, 2004, Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies, Lancet, 363, 157, 10.1016/S0140-6736(03)15268-3

Kawamura, 2002, Transcervical needle biopsy for the differential diagnosis between uterine sarcoma and leiomyoma, Cancer, 94, 1713, 10.1002/cncr.10382

Tsujimura, 2002, Telomerase activity in needle biopsied uterine myoma-like tumors: differential diagnosis between uterine sarcomas and leiomyomas, Int J Oncol, 20, 361

Blake-Mortimer, 2004, Cytotoxic T lymphocyte count and survival time in women with metastatic breast cancer, Breast J, 10, 195, 10.1111/j.1075-122X.2004.21290.x

Anthony, 1982, Blood basophils in lung cancer, Br J Cancer, 45, 209, 10.1038/bjc.1982.35

Lin, 2004, Role of infiltrated leucocytes in tumour growth and spread, Br J Cancer, 90, 2053, 10.1038/sj.bjc.6601705

Patsner, 1988, Use of serum CA-125 in monitoring patients with uterine sarcoma. A preliminary report, Cancer, 62, 1355, 10.1002/1097-0142(19881001)62:7<1355::AID-CNCR2820620719>3.0.CO;2-4

Ray-Coquard, 2009, Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas, Cancer Res, 69, 5383, 10.1158/0008-5472.CAN-08-3845

Nordal, 1995, The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma, Acta Oncol, 34, 797, 10.3109/02841869509127189

Wolfson, 1994, A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas, Gynecol Oncol, 42, 56, 10.1006/gyno.1994.1011

Park, 2008, Role of PET or PET/CT in the post-therapy surveillance of uterine sarcoma, Gynecol Oncol, 109, 255, 10.1016/j.ygyno.2008.01.030

McMillan, 2009, Systemic inflammation, nutritional status and survival in patients with cancer, Curr Opin Clin Nutr Metab Care, 12, 223, 10.1097/MCO.0b013e32832a7902